These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6970809)

  • 1. Antinuclear antibodies related to acetylator phenotype in mice.
    Tannen RH; Weber WW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):485-90. PubMed ID: 6970809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
    Woosley RL; Drayer DE; Reidenberg MM; Nies AS; Carr K; Oates JA
    N Engl J Med; 1978 May; 298(21):1157-9. PubMed ID: 306574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic studies on the drug-related lupus syndrome. Differences in antinuclear antibody development and drug-induced DNA damage in rapid and slow acetylator animal models.
    Weber WW; Tannen RH
    Arthritis Rheum; 1981 Aug; 24(8):979-86. PubMed ID: 6974557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
    Martell KJ; Levy GN; Weber WW
    Mol Pharmacol; 1992 Aug; 42(2):265-72. PubMed ID: 1513324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inheritance of acetylator phenotype in mice.
    Tannen RH; Weber WW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):480-4. PubMed ID: 6970808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
    Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
    Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide.
    Mongey AB; Sim E; Risch A; Hess E
    J Rheumatol; 1999 Aug; 26(8):1721-6. PubMed ID: 10451068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procainamide, a drug causing lupus, induces prostaglandin H synthase-2 and formation of T cell-sensitizing drug metabolites in mouse macrophages.
    Goebel C; Vogel C; Wulferink M; Mittmann S; Sachs B; Schraa S; Abel J; Degen G; Uetrecht J; Gleichmann E
    Chem Res Toxicol; 1999 Jun; 12(6):488-500. PubMed ID: 10368311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
    Reidenberg MM; Drayer DE
    Angiology; 1986 Dec; 37(12 Pt 2):968-71. PubMed ID: 2433971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No demonstrable relationship between IgM and IgG antinuclear antibody levels and acetylator phenotype in patients with systemic lupus erythematosus.
    Portanova JP; Small CJ; Kohler PF
    Arthritis Rheum; 1985 Sep; 28(9):995-8. PubMed ID: 3899125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains.
    Hein DW; Smolen TN; Fox RR; Weber WW
    J Pharmacol Exp Ther; 1982 Oct; 223(1):40-4. PubMed ID: 7120125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of discoid lupus erythematosus with sulfasalazine: 11 cases].
    Delaporte E; Catteau B; Sabbagh N; Gosselin P; Breuillard F; Doutre MS; Broly F; Piette F; Bergoend H
    Ann Dermatol Venereol; 1997; 124(2):151-6. PubMed ID: 9740825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
    Chung JG; Levy GN; Weber WW
    Drug Metab Dispos; 1993; 21(6):1057-63. PubMed ID: 7905384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster.
    Hein DW; Kirlin WG; Ferguson RJ; Weber WW
    J Pharmacol Exp Ther; 1985 Aug; 234(2):358-64. PubMed ID: 3874952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic differences in 2-aminofluorene pharmacokinetics between intact C57BL/6J and A/J mice.
    Hultin TA; Weber WW
    Drug Metab Dispos; 1985; 13(2):148-50. PubMed ID: 2859160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug acetylator phenotypes in newborn infants.
    Szórády I; Sánta A; Veress I
    Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):23-5. PubMed ID: 3580445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation of dapsone by human whole blood.
    Irshaid YM; al-Hadidi HF; Abuirjeie MA; Rawashdeh NM; Gharaibeh NS
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):18-22. PubMed ID: 8444513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced systemic lupus erythematosus.
    Weinstein A
    Prog Clin Immunol; 1980; 4():1-21. PubMed ID: 6992215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inheritance of liver N-acetyltransferase activity in the rapid and slow acetylator inbred hamster.
    Hein DW; Kirlin WG; Ferguson RJ; Weber WW
    J Pharmacol Exp Ther; 1985 Jun; 233(3):584-7. PubMed ID: 3874278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.